Lin, D.; Yu, W.; Yu, J.; Cheng, S.; Song, Y.; Wan, X.; Xu, Y.; Luo, H.; Sun, B.
Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428. Pharmaceuticals 2025, 18, 815.
https://doi.org/10.3390/ph18060815
AMA Style
Lin D, Yu W, Yu J, Cheng S, Song Y, Wan X, Xu Y, Luo H, Sun B.
Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428. Pharmaceuticals. 2025; 18(6):815.
https://doi.org/10.3390/ph18060815
Chicago/Turabian Style
Lin, Dengxiao, Wenfeng Yu, Jia Yu, Sha Cheng, Yu Song, Xiaoqing Wan, Yingjiang Xu, Heng Luo, and Baofei Sun.
2025. "Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428" Pharmaceuticals 18, no. 6: 815.
https://doi.org/10.3390/ph18060815
APA Style
Lin, D., Yu, W., Yu, J., Cheng, S., Song, Y., Wan, X., Xu, Y., Luo, H., & Sun, B.
(2025). Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428. Pharmaceuticals, 18(6), 815.
https://doi.org/10.3390/ph18060815
